ATC Group: A10BF01 Acarbose

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of A10BF01 in the ATC hierarchy

Level
Code
Title
1
Alimentary tract and metabolism
2
Drugs used in diabetes
3
Blood glucose lowering drugs, excl. insulins
4
Alpha glucosidase inhibitors
5
A10BF01
Acarbose

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route
Amount
ORAL - Oral
0.3 g

Active ingredients in A10BF01

Active Ingredient
Description

Acarbose is an alpha-glucosidase inhibitors, used in the treatment of diabetes. Inhibitors of a-glucosidase retard the breakdown of carbohydrates in the food and reduce the increase in blood glucose levels, which occurs after each meal.

Medicines in this ATC group

Drug
Countries

New Zealand

Turkey

Hong Kong

New Zealand

Turkey

Poland

Turkey

Hong Kong

Singapore

Turkey

Australia Austria Brazil Canada Estonia ...

France Tunisia

Tunisia

Australia

Hong Kong

Related product monographs

Title
Type
Country
Summary of Product Characteristics (SPC)
UK